CHEK1 and cancer: ,71,72 Moreover, inhibitors targeting different stages of the cell cycle, such as ATM inhibitors, ATR inhibitors, WEE1 inhibitors, and CHK1 inhibitors, have been developed in recent years, and their combination with PARP inhibitors has demonstrated enhanced anti-cancer efficacy.29